Philadelphia Trust Company’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,734
Closed -$126K 274
2025
Q3
$126K Hold
12,734
0.01% 253
2025
Q2
$114K Sell
12,734
-139,474
-92% -$1.18M 0.01% 239
2025
Q1
$1.33M Sell
152,208
-58,805
-28% -$617K 0.11% 103
2024
Q4
$2.63M Sell
211,013
-314,505
-60% -$3.87M 0.19% 79
2024
Q3
$6.1M Buy
525,518
+18,959
+4% +$219K 0.44% 57
2024
Q2
$5.38M Buy
506,559
+96,436
+24% +$1.07M 0.42% 55
2024
Q1
$4.9M Buy
410,123
+233,141
+132% +$2.81M 0.39% 60
2023
Q4
$1.92M Buy
176,982
+115,000
+186% +$1.1M 0.18% 85
2023
Q3
$611K Buy
+61,982
New +$645K 0.06% 136

Other funds holding VTRS

Philadelphia Trust Company's VTRS Position: Q4 2025 in Review

Philadelphia Trust Company sold out of Viatris (VTRS) in Q4 2025, closing a stake of 12,734 shares — an estimated $126K sold.

Philadelphia Trust Company first reported a position in VTRS in Q3 2023 and held it in 9 quarters. The position peaked at $6.1M in Q3 2024. 1,005 funds tracked by Wall St. Rank hold VTRS as of Q4 2025.

  • Philadelphia Trust Company reported no remaining Viatris position as of Q4 2025 after selling out during the quarter.
  • Philadelphia Trust Company sold 12,734 Viatris shares in Q4 2025, an estimated $126K.
  • Philadelphia Trust Company first reported a position in Viatris in Q3 2023 and held it in 9 quarters.
  • Philadelphia Trust Company's Viatris position peaked at $6.1M in Q3 2024.
  • 1,005 funds tracked by Wall St. Rank held Viatris as of Q4 2025.

Based on Philadelphia Trust Company's 13F filing for Q4 2025, filed 12 Feb 2026.